Garel M C, Joulin V, Le Boulch P, Calvin M C, Préhu M O, Arous N, Longin R, Rosa R, Rosa J, Cohen-Solal M
Institut National de la Santé et de la Recherche Médicale Unité 91,Hôpital Henri Mondor, Créteil, France.
J Biol Chem. 1989 Nov 15;264(32):18966-72.
Bisphosphoglycerate mutase is an erythrocyte-specific enzyme whose main function is to synthesize 2,3-diphosphoglycerate, the allosteric effector of hemoglobin. In addition to its main 2,3-diphosphoglycerate synthase activity, the enzyme displays phosphatase and mutase activities both involving 2,3-diphosphoglycerate in their reaction. The three activities have been demonstrated to be catalysed at a unique active site. To study the structure of such an active site we have developed a recombinant system producing mutants of human bisphosphoglycerate mutase in Escherichia coli, by site-directed mutagenesis. For this purpose the human bisphosphoglycerate mutase cDNA that we had previously cloned has been used to construct a procaryotic high level expression vector bearing the "tac" promoter. Human bisphosphoglycerate mutase produced in E. coli, a species which does not normally synthesize this enzyme, represented 8% of the total soluble bacterial protein and displayed the three catalytic activities (synthase, mutase, and phosphatase) characteristic of the enzyme. Since it has been suggested that the carboxyl-terminal region may be implicated in the catalytic activity of the enzyme, three variants deleted in this part of the protein were produced. Our results indicate that a minimal deletion of 7 amino acid residues in the carboxyl-terminal portion of the human bisphosphoglycerate mutase completely abolished the three catalytic activities of the enzyme. In contrast, the effects of the deletion of the last two lysine residues were limited to a 38% reduction in the synthase activity. These results show that the carboxyl-terminal amino acid residues are either directly or indirectly implicated in the three catalytic functions of the human bisphosphoglycerate mutase, and that the two terminal lysine residues are not essential for the major part of the enzymatic mechanism of the enzyme.
二磷酸甘油酸变位酶是一种红细胞特异性酶,其主要功能是合成2,3 -二磷酸甘油酸,即血红蛋白的变构效应剂。除了其主要的2,3 -二磷酸甘油酸合酶活性外,该酶还表现出磷酸酶和变位酶活性,二者的反应均涉及2,3 -二磷酸甘油酸。已证明这三种活性是在一个独特的活性位点催化的。为了研究这样一个活性位点的结构,我们通过定点诱变开发了一种在大肠杆菌中产生人二磷酸甘油酸变位酶突变体的重组系统。为此,我们先前克隆的人二磷酸甘油酸变位酶cDNA已被用于构建一个带有“tac”启动子的原核高水平表达载体。在通常不合成这种酶的大肠杆菌中产生的人二磷酸甘油酸变位酶占细菌总可溶性蛋白的8%,并表现出该酶特有的三种催化活性(合酶、变位酶和磷酸酶)。由于有人提出羧基末端区域可能与该酶的催化活性有关,因此产生了该蛋白这一部分缺失的三种变体。我们的结果表明,人二磷酸甘油酸变位酶羧基末端部分最少缺失7个氨基酸残基会完全消除该酶的三种催化活性。相比之下,最后两个赖氨酸残基缺失的影响仅限于合酶活性降低38%。这些结果表明,羧基末端氨基酸残基直接或间接参与了人二磷酸甘油酸变位酶的三种催化功能,并且这两个末端赖氨酸残基对于该酶的主要酶促机制不是必需的。